Strides Pharma Science has reported results for third quarter ended December 31, 2019.
The company has reported a fall of 10.84% in its net profit at Rs 13.65 crore for the quarter under review as compared to Rs 15.31 crore for the same quarter in the previous year. Total income of the company decreased by 12.52% at Rs 382.09 crore for Q3FY20 as compared Rs 436.75 crore for the corresponding quarter previous year.
On the consolidated basis, the company has reported a fall of 68% in its net profit attributed to the owners at Rs 93.89 crore for the quarter under review as compared to Rs 293.42 crore for the same quarter in the previous year. However, total income of the company increased by 28.49% at Rs 744.66 crore for Q3FY20 as compared Rs 579.54 crore for the corresponding quarter previous year.
